课题基金 / 基金详情

Immunotherapeutic analysis using newly established murine models for Sjogren' s syndrome

Immunotherapeutic analysis using newly established murine models for Sjogren' s syndrome
使用新建立的干燥综合征小鼠模型进行免疫治疗分析
批准号:
21249090
负责人:
HAYASHI Yoshio
金额:
$29.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

HAYASHI Yoshio的其他基金

相似基金

相关文献

中文摘要
翻译
我们报道了RbAp48和CCR7基因敲除(KO)小鼠的转基因(TG)表达导致了类似干燥S综合征的自身免疫性外分泌病的发生。随着年龄的增长,CD4~+T细胞介导的自身免疫损伤加重,并与自身抗体的产生有关。我们发现唾液上皮细胞可以产生干扰素-γ和白介素18,从而激活干扰素调节因子-1和第二类反式激活因子。CCR7KO小鼠的调节性T(Treg)细胞明显滞留在淋巴结内,不能在外分泌器官内巡逻以保护自身免疫。靶向RbAp48基因并应用体内siRNA给药可预防自身免疫性损伤。这些结果表明上皮细胞的一种新的免疫活性作用,导致在发展基于性别的自身免疫之前失去局部耐受性。
英文摘要
We reported that transgenic(TG) expression of RbAp48, and CCR7 knockout(KO) mice resulted in the development of autoimmune exocrinopathy resembling Sjogren' s syndrome. CD4^+ T cell-mediated autoimmune lesions were aggravated with age, in association with autoantibody productions. We obtained evidences that salivary epithelial cells can produce interferon-γand interleukin-18, which activates interferon regulatory factor-1(IRF-1), and class II transactivator(CIITA). Regulatory T(Treg) cells were significantly retained in the lymph nodes of CCR7KO mice, and failed to patrol within the exocrine organs to protect autoimmunity. The gene targeting for RbAp48 with application of in vivo siRNA administration prevented autoimmune lesions. These results indicate a novel immunocompetent role of epithelial cells, resulting in loss of local tolerance prior to developing gender-based autoimmunity.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
Real-time in vivo imaging of p16Ink4a reveals cross talk with p53.
P16INK4A的实时体内成像揭示了与p53的交叉对话。
DOI: 10.1083/jcb.200904105
发表时间: 2009-08-10
期刊: The Journal of cell biology
影响因子: --
作者: [Yamakoshi K, Takahashi A, Hirota F, Nakayama R, Ishimaru N, Kubo Y, Mann DJ, Ohmura M, Hirao A, Saya H, Arase S, Hayashi Y, Nakao K, Matsumoto M, Ohtani N, Hara E]
通讯作者: Hara E
DOI: 10.1371/journal.pone.0019017
发表时间: 2011-04-22
期刊: PloS one
影响因子: 3.7
作者: [Watanabe M, Ishimaru N, Ashrin MN, Arakaki R, Yamada A, Ichikawa T, Hayashi Y]
通讯作者: Hayashi Y
シェーグレン症候群における調節性T細胞の役割
调节性 T 细胞在干燥综合征中的作用
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Yamada, E., Inoue, C., Oda, K., Kobayashi, T., Hayashi, Y.,Onbe, H., Yokoyama, E., Shimomura, Y., Kawaguchi, T., 石丸直澄]
通讯作者: 石丸直澄
Critical Signaling Pathway via CCR7 of Foxp3+CD25+CD4+ Regulatory T Cells for the Egress from Lymph Nodes
Foxp3 CD25 CD4 调节性 T 细胞通过 CCR7 进行淋巴结出口的关键信号通路
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [大西和子, 辻川真弓, 吉田和江, 後藤姉奈, 町本美保, 大石ふみ子, 山田章子, 石丸直澄]
通讯作者: 石丸直澄
共 69 条
    Study on Medicinal Chemistry of Reversible Cysteine Protease Inhibitors for the Treatment of Infectious Diseases
    • 批准号:
      23659059
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      HAYASHI Yoshio
    • 依托单位:
    Integrated medicinal chemistry research of intractable diseases based on peptidic small molecules
    Study on Medicinal Chemistry, Chemical Biology and Chemical Pharmaceutics of Anticancer Drug Based on the Microtubule Targeting Agents
    Molecular analysis of pathogenesis on Sjogren's syndrome and its application of new diagnosis and therapy
    • 批准号:
      17109016
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $61.98万
    • 财政年份:
      2005
    • 负责人:
      HAYASHI Yoshio
    • 依托单位:
    海外基金